These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34945772)

  • 1. Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation.
    Lee WC; Lee CF; Wu TH; Hung HC; Lee JC; Wang YC; Cheng CH; Wu TJ; Chou HS; Chan KM
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC; Kim SH; Shim JR; Park SJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation.
    Won D; Choe W; Kim HJ; Kwon SW; Han DJ; Park SK
    J Clin Apher; 2014 Oct; 29(5):243-50. PubMed ID: 24375675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.
    Kanazawa H; Fukuda A; Mali VP; Rahayatri TH; Hirata Y; Sasaki K; Uchida H; Shigeta T; Sakamoto S; Matsumoto K; Kasahara M
    Pediatr Transplant; 2016 May; 20(3):401-7. PubMed ID: 27012966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.
    Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW
    J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quick preparation of ABO-incompatible living donor liver transplantation for acute liver failure.
    Lee WC; Cheng CH; Lee CF; Hung HC; Lee JC; Wu TH; Wang YC; Wu TJ; Chou HS; Chan KM
    Clin Transplant; 2022 Mar; 36(3):e14555. PubMed ID: 34874071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange.
    Uchiyama H; Mano Y; Taketomi A; Soejima Y; Yoshizumi T; Ikegami T; Shirabe K; Maehara Y
    Transplantation; 2011 Nov; 92(10):1134-9. PubMed ID: 21946174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult Living Donor Liver Transplantation Across ABO-Incompatibility.
    Lee CF; Cheng CH; Wang YC; Soong RS; Wu TH; Chou HS; Wu TJ; Chan KM; Lee CS; Lee WC
    Medicine (Baltimore); 2015 Oct; 94(42):e1796. PubMed ID: 26496313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO-incompatible living-donor kidney transplantation in children.
    Shishido S; Asanuma H; Tajima E; Hoshinaga K; Ogawa O; Hasegawa A; Honda M; Nakai H
    Transplantation; 2001 Sep; 72(6):1037-42. PubMed ID: 11579297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.
    Lee SD; Kim SH; Kong SY; Kim YK; Park SJ
    Transpl Immunol; 2015 Jan; 32(1):29-34. PubMed ID: 25449537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative ABO Blood Group Isoagglutinin Titer and the Risk of Acute Kidney Injury after ABO-Incompatible Living Donor Liver Transplantation.
    Cho H; Bae J; Yoon HK; Lee HJ; Yang SM; Choe SH; Jung CW; Suh KS; Kim WH
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-incompatible kidney transplantation can be successfully conducted by monitoring IgM isoagglutinin titers during desensitization.
    Kim H; Choe W; Shin S; Kim YH; Han DJ; Park SK; Kwon SW; Ko DH
    Transfusion; 2020 Mar; 60(3):598-606. PubMed ID: 31957888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
    Kim JD; Choi DL; Kim SG; Lee AJ
    Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of isoagglutinin titre with the current desensitization protocol in ABO-incompatible kidney transplantation.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Nephrology (Carlton); 2019 Jun; 24(6):654-660. PubMed ID: 29877001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO-incompatible living donor liver transplantation with high preoperative antibody titer: A case report.
    Saitoh Y; Fujio A; Miyagi S; Tokodai K; Unno M; Kamei T
    Int J Surg Case Rep; 2021 Aug; 85():106260. PubMed ID: 34343790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
    Soin AS; Raut V; Mohanka R; Rastogi A; Goja S; Balachandran M; Saigal S; Saraf N; Bhangui P; Sumana KR; Singla P; Srinivasan T; Choudhary N; Tiwari A; Raina V; Govil D; Mohan N; Vohra V
    Indian J Gastroenterol; 2014 Jan; 33(1):72-6. PubMed ID: 24369388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative rebound of antiblood type antibodies and antibody-mediated rejection after ABO-incompatible living-related kidney transplantation.
    Ishida H; Kondo T; Shimizu T; Nozaki T; Tanabe K
    Transpl Int; 2015 Mar; 28(3):286-96. PubMed ID: 25363583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.